Two plus one

I was tempted by “Gene-Mapping Initiative Takes Aim at Disease,” Wall Street Journal, January 31, 2015 A3, dealing with the government’s proposal to gather and study a collection of genetic data on a bunch of its citizens.  Pay no attention to the article the other day about what you can learn from anonymized information.

I also looked closely at “Debate Heightens Over Measuring Health-Care Quality,” Wall Street Journal, January 31, 2015 A3, which discusses, briefly, possible metrics to measure the quality, versus the quantity, of medical care.  And metrics are a part of analytics.

But I decided to go with “Pom’s Ads Misled Consumers, Court Says,” Wall Street Journal, January 31, 2015 B3. The FTC pops a company for implying health benefits from drinking its pomegranate-flavored juice.  One documented trial establishing the health benefits would be enough. Commercial speech can’t be deceptive.

Are deceptive ad claims within the ambit of information governance?


Leave a comment

Filed under Analytics, Business Case, Collect, Communications, Compliance, Controls, Definition, Governance, Information, Legal, Oversight, Protect information assets, Requirements, Risk, Use, Value

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s